We are live on ! Find out more
IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Delisted

IDXG was delisted on the 24th of February, 2021.

Back to rankings

44 hedge funds and large institutions have $37.9M invested in Interpace Biosciences, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

IDXG Hedge Fund Activity: Q2 2013 in Review

44 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Interpace Biosciences, Inc. Common Stock (IDXG) for Q2 2013, worth a combined $37.9M.

Buyers outnumbered sellers: 44 funds opened new IDXG positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

  • 44 institutional investors held Interpace Biosciences, Inc. Common Stock (IDXG) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $37.9M of Interpace Biosciences, Inc. Common Stock stock for Q2 2013.
  • 44 funds opened new Interpace Biosciences, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +44 holders.

Based on aggregated 13F filings for Q2 2013.